EdgarLookup

Allogene Therapeutics, Inc. — All Filings

537 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 144/A 3 4 4/A 424B4 424B5 5 8-A12B 8-K 8-K/A ARS CERT CORRESP CT ORDER D DEF 14A DEFA14A DRS EFFECT POS EX POS462B POSASR PRE 14A S-1 S-1/A S-1MEF S-3 S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 PRIMARY DOCUMENT 0001214659-21-003612 Mar 30, 2021 Mar 26, 2021
4 PRIMARY DOCUMENT 0001214659-21-003242 Mar 17, 2021 Mar 15, 2021
4 PRIMARY DOCUMENT 0001214659-21-003238 Mar 17, 2021 Mar 15, 2021
4 PRIMARY DOCUMENT 0001214659-21-003241 Mar 17, 2021 Mar 15, 2021
4 PRIMARY DOCUMENT 0001214659-21-003240 Mar 17, 2021 Mar 15, 2021
4 PRIMARY DOCUMENT 0001214659-21-003239 Mar 17, 2021 Mar 15, 2021
10-K 10-K 0001737287-21-000009 Feb 25, 2021 Dec 31, 2020
S-8 S-8 0001737287-21-000010 Feb 25, 2021
8-K 8-K 0001737287-21-000007 Feb 25, 2021
SC 13G SEC SCHEDULE 13G 0001562230-21-000081 Feb 16, 2021
SC 13G/A SEC SCHEDULE 13G 0001422848-21-000096 Feb 16, 2021
SC 13G/A SC 13G/A 0001193125-21-041125 Feb 12, 2021
SC 13G/A SC 13G/A 0001193125-21-040876 Feb 12, 2021
5 PRIMARY DOCUMENT 0001214659-21-001199 Feb 3, 2021 Dec 31, 2020
4 PRIMARY DOCUMENT 0001214659-21-000617 Jan 19, 2021 Jan 14, 2021
4 PRIMARY DOCUMENT 0001214659-20-010544 Dec 18, 2020 Dec 17, 2020
8-K 8-K 0001737287-20-000064 Dec 15, 2020 Dec 14, 2020
8-K 8-K 0001737287-20-000061 Dec 7, 2020 Dec 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-009726 Nov 18, 2020 Nov 16, 2020
8-K 8-K 0001737287-20-000055 Nov 4, 2020
10-Q 10-Q 0001737287-20-000059 Nov 4, 2020 Sep 30, 2020
8-K/A 8-K/A 0001737287-20-000050 Oct 26, 2020 Jun 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-008703 Oct 16, 2020 Oct 15, 2020
4 PRIMARY DOCUMENT 0001214659-20-008571 Oct 13, 2020 Oct 12, 2020
4 PRIMARY DOCUMENT 0001214659-20-008532 Oct 9, 2020 Oct 8, 2020
4 PRIMARY DOCUMENT 0001214659-20-008506 Oct 8, 2020 Oct 6, 2020
4 PRIMARY DOCUMENT 0001214659-20-008504 Oct 8, 2020 Oct 6, 2020
4 PRIMARY DOCUMENT 0001214659-20-008508 Oct 8, 2020 Oct 7, 2020
4 PRIMARY DOCUMENT 0001214659-20-008378 Oct 2, 2020 Oct 1, 2020
4 PRIMARY DOCUMENT 0001214659-20-008375 Oct 2, 2020 Oct 1, 2020
4 PRIMARY DOCUMENT 0001214659-20-008039 Sep 22, 2020 Sep 21, 2020
4 PRIMARY DOCUMENT 0001214659-20-007671 Sep 3, 2020 Sep 1, 2020
4 PRIMARY DOCUMENT 0001214659-20-007184 Aug 14, 2020 Aug 13, 2020
4 OWNERSHIP DOCUMENT 0001387131-20-007268 Aug 10, 2020 Aug 6, 2020
SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-20-007266 Aug 10, 2020
8-K 8-K 0001737287-20-000045 Aug 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-006805 Aug 5, 2020 Aug 3, 2020
10-Q 10-Q 0001737287-20-000047 Aug 5, 2020 Jun 30, 2020
SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-20-006309 Jul 10, 2020
4 OWNERSHIP DOCUMENT 0001387131-20-006093 Jun 30, 2020 Jun 26, 2020
4 OWNERSHIP DOCUMENT 0001387131-20-005972 Jun 25, 2020 Jun 23, 2020
4 0001387131-20-005873 Jun 22, 2020 Jun 18, 2020
4 OWNERSHIP DOCUMENT 0001387131-20-005745 Jun 17, 2020 Jun 15, 2020
8-K 8-K 0001737287-20-000041 Jun 11, 2020 Jun 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-005493 Jun 9, 2020 Jun 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-005494 Jun 9, 2020 Jun 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-005495 Jun 9, 2020 Jun 5, 2020
4 PRIMARY DOCUMENT 0001214659-20-005496 Jun 9, 2020 Jun 5, 2020
4 OWNERSHIP DOCUMENT 0001387131-20-005509 Jun 5, 2020 Jun 3, 2020
8-K 8-K 0001737287-20-000039 Jun 4, 2020 Jun 1, 2020